Research > ETFs > ETF / ETP Commentary > 

Value’s Comeback: How VLUE Beats Market-Cap Weighting

2026 is proving that value is alive and well, but certain value-focused ETFs have been standout performers relative to their factor peers. Such is the case with the iShares MSCI USA Value Factor ETF (VLUE B-), which is up over 40% for the year. It’s easily outpacing its value sibling, the iShares S&P 500 Value ETF (IVE B+), — proving that its enhanced methodology can outperform a simple market-cap weighted approach.Key Takeaways: VLUE is outperforming standard benchmarks in 2026 with a year-to-date gain over 40%. This demonstrates how systematic multi-metric screening can avoid classic value traps and outperform traditional market-cap-weighted strategies like IVE. VLUE achieves its distinct factor tilt through a highly concentrated 152-holding portfolio. It allocates 42.5% of total capital to its top 10 positions — led by a 19% weight in Micron Technology. This results in a 36.2% tech allocation that nearly doubles IVE’s sector footprint. Featuring a competitive 0.15% expense ratio, VLUE delivers enhanced factor exposure with passive ETF tax efficiency. The fund has distributed zero capital gains since its 2013 inception compared to the 8% average annual distribution typical of active large-cap value mutual funds. See More: Value in Latin America’s Giant? Opportunities in BrazilInside VLUE's Value IndexDesigned for investors seeking enhanced long-term returns by targeting large-cap stocks priced at a fundamental discount, VLUE is built around systematic, factor-driven precision. It all begins with VLUE tracking the MSCI USA Enhanced Value Index, which draws from a selection universe of large- and mid-cap U.S. equities. Its prime differentiator is that the Index methodology goes beyond basic fundamental valuation metrics. To avoid classic value traps, the index screens holdings using a rigorous composite of three fundamental valuation metrics. First and foremost, a low price-to-book value ratio identifies deeply undervalued companies relative to their balance sheet assets. Next, the low forward price-to-earnings metric isolates companies trading at attractive valuations based on their near-term earning power. Lastly, the low enterprise value-to-operating cash flow screens for companies exhibiting operational profitability while systematically reducing exposure to those that are highly levered. In the end, this multifaceted screening approach identifies fundamentally sound businesses while reducing exposure to over-leveraged risk.Portfolio Holdings and Concentration AnalysisA direct comparison of portfolio structures for VLUE and IVE further highlights why the former achieves more targeted factor exposure than standard value benchmarks. Maintaining a highly concentrated approach with just 152 total holdings, VLUE places 42.5% of its capital in its top 10 positions. This results in an effective number of holdings of 21 and an effective holdings ratio of 0.14. Its largest conviction position, Micron Technology, accounts for an influential 19% of the fund, followed by Cisco Systems, Inc. at 4.66%. This underscores the fund’s heavy tech focus, with VLUE allocating 36.2% to the sector compared to IVE’s 18.7%. This is nearly double the exposure, which served as VLUE’s primary performance driver during tech’s rally. In contrast, IVE offers a broader, less concentrated portfolio of 437 holdings that results in an effective number of 81 holdings and an effective holdings ratio of 0.19. Capital in IVE’s top 10 allocations represents only 23.62% of the fund, which is dominated by household mega-cap names such as Apple and Amazon. With only a 23% holdings overlap between the two funds, this comparison underscores how dramatically value ETF strategies can diverge.Low Costs and Tax EfficiencyPunctuating VLUE’s strong performance is its low cost and tax efficiency. While active value managers often incur high expense burdens and taxable turnover, VLUE bridges the gap between active management insights and passive ETF efficiency. The fund carries a competitive expense ratio of just 0.15% to access its factor-screening techniques. Furthermore, the fund offers structural tax advantages. Since its inception in April 2013, VLUE has never paid out a capital gains distribution. By comparison, active mutual funds in the Morningstar Large Cap Value category have averaged annual capital gains distributions of 8%. By capturing undervalued companies using its enhanced index methodology, VLUE demonstrates how a rules-based factor strategy can outperform broader value benchmarks. For more news, information, and strategy, visit the Smart Beta Content Hub.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.